| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 5.56B | 5.39B | 4.82B | 5.48B | 6.36B |
| Gross Profit | 1.01B | 1.05B | 907.20M | 841.93M | 1.01B |
| EBITDA | 537.89M | 554.37M | 567.51M | 520.78M | 595.25M |
| Net Income | 380.63M | 383.90M | 328.86M | 296.90M | 378.62M |
Balance Sheet | |||||
| Total Assets | 5.52B | 5.41B | 4.32B | 3.89B | 4.17B |
| Cash, Cash Equivalents and Short-Term Investments | 984.47M | 345.03M | 828.03M | 511.97M | 351.70M |
| Total Debt | 839.81M | 705.14M | 713.29M | 476.61M | 611.50M |
| Total Liabilities | 3.30B | 3.56B | 2.67B | 2.48B | 2.86B |
| Stockholders Equity | 2.18B | 1.86B | 1.66B | 1.41B | 1.30B |
Cash Flow | |||||
| Free Cash Flow | 19.23M | 420.91M | 177.02M | 359.69M | -326.76M |
| Operating Cash Flow | 353.41M | 813.65M | 484.70M | 595.93M | 245.16M |
| Investing Cash Flow | -385.73M | -358.76M | -294.97M | -230.02M | -607.42M |
| Financing Cash Flow | -12.18M | -276.43M | -377.27M | -191.03M | 220.38M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | HK$43.38B | 44.26 | 22.19% | 0.17% | 67.95% | 73.01% | |
70 Outperform | HK$3.09B | 5.82 | 18.00% | 5.75% | 3.21% | -0.86% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
57 Neutral | HK$580.00M | -6.86 | -9.29% | 7.47% | -23.05% | -511.63% | |
55 Neutral | HK$1.26B | 12.35 | 19.99% | ― | 11.61% | 287.50% | |
52 Neutral | HK$1.37B | -2.34 | -3.73% | 6.40% | -34.79% | -130.42% |